4565-31-5

Basic information

• Product Name: 5-FORMYL-2-THIOPHENECARBOXYLIC ACID
• Synonyms: AKOS MSC-0225;5-FORMYLTHENOIC ACID;5-FORMYL-THIOPHENE-2-CARBOXYLIC ACID;5-FORMYL-THIOPHEN-2-CARBOXYLIC ACID;5-FORMYL-2-THIOPHENECARBOXYLIC ACID;AURORA KA-6755;5-Formyl-2-thiophenecarboxylic acid ,98%;5-ForMyl-thiophene-2-carboxylic acid aMide
• CAS NO: 4565-31-5
• Molecular Formula: C₆H₄O₃S
• Molecular Weight: 156.16
• Product Categories: Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Sulfur & Selenium Compounds
• Mol File: 4565-31-5.mol
• Article Data: 8

Chemical Properties

• Melting Point: 169 °C
• Boiling Point: 371.378 °C at 760 mmHg
• Flash Point: 178.403 °C
• Appearance: /
• Density: 1.515 g/cm³
• Vapor Pressure: 3.58E-06mmHg at 25°C
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 3.05±0.10(Predicted)
• CAS DataBase Reference: 5-FORMYL-2-THIOPHENECARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 5-FORMYL-2-THIOPHENECARBOXYLIC ACID(4565-31-5)
• EPA Substance Registry System: 5-FORMYL-2-THIOPHENECARBOXYLIC ACID(4565-31-5)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38-36
• Safety Statements: 26-36
• Hazardous Substances Data: 4565-31-5(Hazardous Substances Data)

Usage

Uses

5-Formyl-2-thiophenecarboxylic acid is a thiophene derivative as immunomodulating agents useful in the treatment of autoimmune diseases.

InChI:InChI=1/C6H4O3S/c7-3-4-1-2-5(10-4)6(8)9/h1-3H,(H,8,9)/p-1

Upstream product

• 67808-64-4 5-formyl-thiophene-2-carboxylic acid methyl ester 
• 932-95-6 2,5-thiophenedicarboxaldehyde 
• 58268-08-9 2-(2-thienyl)-1,3-dioxolane 
• 124-38-9 carbon dioxide 
• 98-03-3 thiophene-2-carbaldehyde 
• 104208-13-1 1,3-dimethyl-2-(thiophen-2-yl)imidazolidine 

Downstream Products

• 3779-27-9 2,2'-bithiophene-5-carboxaldehyde 
• 877842-09-6 5-(3-oxo-3H-isobenzofuran-1-ylidenemethyl)-thiophene-2-carboxylic acid 
• 1236291-26-1 (Z)-5-{6-[3-(4-methoxyphenyl)-ureido]-2-oxo-1,2-dihydro-indol-3-ylidene-methyl}thiophene-2-carboxylic acid 
• 1512637-49-8 5-(2-methyl-2-methoxycarbonylpropyl)thiophene-2-carboxylic acid tert-butyl ester 
• 1160956-65-9 C₂₀H₂₃N₃O₇S 
• 1225051-43-3 3-(3-thiophene)carboxyl-1-(2,5-dimethoxyphenyl)prop-2-en-1-one 
• 14282-64-5 5-(hydroxymethyl)thiophene-2-carboxylic acid 
• 1092486-10-6 C₂₄H₂₁N₅O₄S 
• 133380-55-9 2-phenyl-3-methyl-5-(5-methoxycarbonyl-2-thenoyl)oxazole N-oxide hydrochloride 
• 2495-15-0 N-(5-methoxycarbonyl-2-thenoyl)-N'-benzoylhydrazide 
• 133380-75-3 O-(2-methoxycarbonyl-5-thenoyl)benzamide oxime 
• 133380-49-1 methyl 5--2-thiophenecarboxylate 
• 133380-43-5 N-(5-methoxycarbonyl-2-thenoyl)-α-aminoacetophenone 
• 133380-57-1 methyl 5-(2-phenyl-3-methyloxazol-5-yl)-2-thiophenecarboxylate 

Relevant articles and documents

Redox-Neutral Photocatalytic C?H Carboxylation of Arenes and Styrenes with CO2

-

NHC-catalysed highly selective aerobic oxidation of nonactivated aldehydes

This publication describes a highly selective oxidation of aldehydes to the corresponding acids or esters. The reaction proceeds under metal-free conditions by using N-heterocyclic carbenes as organocatalysts in combination with environmentally friendly oxygen as the terminal oxidation agent.

2 - SUBSTITUTED HETEROCYCLIC COMPOUNDS AND ANTITUMOR COMPOSITION COMPRISING THE SAME

The present invention relates with 2-substituted heterocyclic compounds and antitumor composition comprising the same. The compound according to the present invention exhibits superior effect as telomerase inhibitor based on new mechanism (terlomere-terlomerase) which can resolve the problems occurring at the time of using chemotherapeutics, i.e side effects and cross resistance between related mechanism on using chemotherapeutics. In addition, the antitumor composition comprising the compound of the present invention exhibits superior effect in inhibiting the growth of cancer cell.